Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
---|
10/20/2004 | EP0830136B1 New cryptophycins from synthesis |
10/20/2004 | CN1171874C Combinations of protein farnesyltransferase and HMG COA reductase inhibitors and their use to treat cancer |
10/20/2004 | CN1171634C Reactor and method for solid phase peptide synthesis |
10/19/2004 | US6806279 For therapy of autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, uveitis, and psoriasis, allograft rejection, and graft-versus-host disease |
10/19/2004 | CA2514441A1 Irreversible caspase-3 inhibitors as active site probes |
10/14/2004 | WO2004087767A1 Polypeptide |
10/14/2004 | WO2004087743A2 Anti-hypertensive peptide derivatives and process for preparation thereof |
10/14/2004 | WO2004087742A2 Peptides for reducing symptoms of toxic shock syndrome and septic shck |
10/14/2004 | WO2004087741A1 Crystalline phases of a potent hcv inhibitor |
10/14/2004 | WO2004087740A2 Preserved and stable compositions containing peptide copper complexes and methods related thereto |
10/14/2004 | WO2004087643A1 Deformylase inhibitor, process for preparing the same, and antibacterial composition comprising the same |
10/14/2004 | WO2004078708A3 Novel method for synthesising derivatives of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro,-ih-indole-2-carboxylic acid and the use thereof for perindopril synthesis |
10/14/2004 | WO2004032827A3 Hepatitis c virus inhibitors |
10/14/2004 | US20040204591 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
10/14/2004 | US20040204582 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
10/14/2004 | US20040204478 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
10/14/2004 | US20040204368 Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient |
10/14/2004 | US20040204364 Peptides for activation and inhibition of deltaPKC |
10/14/2004 | US20040202761 Cocoa flavor precursor peptides |
10/14/2004 | CA2734606A1 Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production |
10/14/2004 | CA2520789A1 Peptides for reducing symptoms of toxic shock syndrome and septic shock |
10/13/2004 | EP1466921A1 Inhibitors of interleukin-1 beta converting enzyme |
10/13/2004 | EP1466917A1 Method for making peptide boronic acids and acids obtainable thereby |
10/13/2004 | EP1466916A1 Peptide boronic acids useful in making salts thereof |
10/13/2004 | EP1466911A2 Preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
10/13/2004 | EP1465918A2 Peptides promoting cell adherence, growth and secretion |
10/13/2004 | EP1465917A1 Intermediates for lhrh antagonist synthesis, process for their production, and process for lhrh antagonist production |
10/13/2004 | EP1465907A2 Modular peptide-based reagent |
10/13/2004 | EP1465891A2 Inhibitors of dipeptidyl peptidase iv |
10/13/2004 | EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto |
10/13/2004 | EP1465866A2 Protease inhibitors of the coagulation cascade isolated from dysidea sponges |
10/13/2004 | EP1465649A2 Methods and compositions for derepression of iap-inhibited caspase |
10/13/2004 | EP1213284B1 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives |
10/13/2004 | EP1131340B1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
10/13/2004 | EP1102763B1 Fsh mimetics for the treatment of infertility |
10/13/2004 | EP0839155B1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES |
10/13/2004 | EP0736036B1 Kininogen inhibitors |
10/13/2004 | CN1536994A Hypoglycemic agent |
10/13/2004 | CN1535980A New compound with cativity for inhibiting glycine transport factor |
10/13/2004 | CN1170842C New amidinobenzylamine derivatives and their use as thrombin inhibitors |
10/13/2004 | CN1170832C Substituted thiazol [3,2-alphal]azatropylidene derivatives |
10/12/2004 | US6803487 Reacting isobutylene, ethylene and mineral acid;hydrolysis of corresponding ester to alcohol; catalytic dehydrogenation |
10/12/2004 | US6803486 Peptidomimetic; n-aminobutyl-n'-nitroguanidine derivatives |
10/12/2004 | US6803466 Effective against drug-resistant mutants |
10/12/2004 | US6803040 Derivatives of tricyclic antidepressants and protein and polypeptide tricyclic antidepressant derivative conjugates and labels |
10/07/2004 | WO2004086039A2 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
10/07/2004 | WO2004085465A1 Phex substrates and methods using same |
10/07/2004 | WO2004084812A2 Tamandarin analogs and fragments thereof and methods of making and using |
10/07/2004 | WO2004043911A3 N-cycloalkylglycines as hiv protease inhibitors |
10/07/2004 | WO2004002418A3 Compositions and methods comprising protein activated receptor antagonists |
10/07/2004 | WO2003059942A3 Peptides and peptidomimetics having anti-proliferative activity and their use |
10/07/2004 | US20040198989 inhibitors of HIV protease for treating AIDS |
10/07/2004 | US20040198988 Novel method for synthesis of (2s, 3as, 7as)-1-{(s)-alanyl}-octahydro-1h-indole-2-carboxylic acid derivatives and use for synthesis of perindopril |
10/07/2004 | US20040198639 Mixture with non-formaldehyde preservative; microbiocides; chemical resistance; drugs, medical equipment, cosmetics; antiaging, wrinkle resistance; skin disorders |
10/07/2004 | US20040197879 1,2,3,4-tetrazol-1-yl-L-alanine or 1,2,3,4-tetrazol-2-yl-L-alanine. |
10/07/2004 | CA2520662A1 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
10/07/2004 | CA2519234A1 Tamandarin analogs and fragments thereof and methods of making and using |
10/06/2004 | EP1463719A2 Eponemycin and epoxomicin analogs and uses thereof |
10/06/2004 | EP1463529A2 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
10/06/2004 | EP1206484B1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
10/06/2004 | EP1085000B1 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt |
10/06/2004 | CN1535281A Peptides and related molecules that bind to TALL-1 |
10/06/2004 | CN1535279A Process for producing dipeptide L-amino acid amide hydrolase to be used therein and process for producing L-amino acid amide hydrolase |
10/06/2004 | CN1535264A Arginine derivatives |
10/06/2004 | CN1169810C Peptide nucleic acid derivatives and preparing process, intermediate for preparing them and medicinal composition containing them |
10/06/2004 | CN1169809C BOC protective beta-tetrahydro carboline carboxylic acid and its nano-preparation, its RGD conjugate, their synthesis and medical application |
10/05/2004 | US6800612 Have vasodilating activity and inhibit the aggregation of the platelets; releasing no |
10/05/2004 | US6800611 Metastin derivatives and their use |
10/05/2004 | US6800287 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
09/30/2004 | WO2004083861A1 Compounds and methods for detecting tripeptidyl protease i |
09/30/2004 | WO2004083258A2 Branched water-soluble polymers and their conjugates |
09/30/2004 | WO2004083238A1 Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
09/30/2004 | WO2004083237A1 Novel method for the synthesis of (2s, 3as, 7as)-perhydroindole-2-carboxylic acid and the esters thereof and application to the synthesis of perindopril |
09/30/2004 | WO2004083236A2 Cancer treatment using proanp peptides |
09/30/2004 | WO2004082709A1 Angiotensin-converting enzyme inhibitory peptides |
09/30/2004 | WO2004082357A2 Novel method for the synthesis of derivatives of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxylic acid and application thereof to the synthesis of perindopril |
09/30/2004 | WO2004062568A3 Conjugate of losartan, valsartan, candesartan or eprosartan and a chelant as contrast agent |
09/30/2004 | WO2004050689A3 Aza-peptides |
09/30/2004 | WO2004050084A3 Ace-inhibitors having antioxidant and nitricoxid-donor activity |
09/30/2004 | WO2003083055A3 Hybridization rate enhancement for substrate-bound specific nucleic acid-binding agents |
09/30/2004 | WO2003031574A3 Elastase inhibitors |
09/30/2004 | WO2003026645A8 Tetrapeptide derivative crystals |
09/30/2004 | US20040192742 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; glomerulonephritis; malaria; oral diseases |
09/30/2004 | US20040192596 Therapeutic fibrin-derived peptides and uses thereof |
09/30/2004 | US20040192588 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
09/30/2004 | US20040191926 Ptp1b inhibitors and ligands |
09/30/2004 | CA2743539A1 Angiotensin-converting enzyme inhibitory peptides |
09/30/2004 | CA2743313A1 Angiotensin-converting enzyme inhibitory peptides |
09/30/2004 | CA2526891A1 Angiotensin-converting enzyme inhibitory peptides |
09/30/2004 | CA2519092A1 Branched water-soluble polymers and their conjugates |
09/30/2004 | CA2518550A1 Cancer treatment using proanp peptides |
09/29/2004 | EP1462455A1 Novel peptides and medicinal uses thereof |
09/29/2004 | EP1461620A2 Flexible method and apparatus for high throughput production and purification of multiple proteins |
09/29/2004 | EP1461069A2 Combined use of a glp-1 compound and another drug for treating dyslipidemia |
09/29/2004 | EP1461001A2 Cancer-associated epitope |
09/29/2004 | EP1351941B1 Bisaryl derivatives having fsh receptor modulatory activity |
09/29/2004 | EP1169339B1 Macrocyclic peptides inhibiting the hepatitis c virus ns3 protease |
09/29/2004 | EP1140980B1 Pseudopeptide compounds having an inhibiting activity with respect to paths activated by proteins with active tyrosine kinase activity and pharmaceutical compositions containing same |
09/29/2004 | EP0983095B1 Peptide-coated implants and methods for producing them |
09/29/2004 | EP0627925B1 Trypsin inhibitors |